Atlas of breast cancer early detection
$ 8.50
-
By A Mystery Man Writer
-
-
4.7(601)
Product Description
Atlas of breast cancer early detection
ATLAS Trial of Continuing Adjuvant Tamoxifen to 10 Years versus Stopping at 5 Years for Early Breast Cancer
Atlas of breast cancer early detection
Atlas of breast cancer early detection
Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study - The Lancet Global Health
PDF] The Circulating Cell-free Genome Atlas (CCGA) Study: Follow-up (F/U) on non-cancer participants with cancer-like cell-free DNA signals.
Changing the future of cancer mortality
Early detection is our most effective means for reducing the number of unnecessary deaths caused by breast cancer; however, the lack of skilled